34c39814f65275e66202c64aeb4daa64  284154.pdf
0da9f89c63bba5ff3a08440588b0efde8923e698  284154.pdf
13ff6c5dfc8a1d0d3fb41a0735064e43954c81a5621401d7e5fb50613fc25d7b  284154.pdf

Title:          Rimeporide as a first- in-class NHE-1 inhibitor_ Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
Subject:        Pharmacological Research, 159 (2020) 104999. doi:10.1016/j.phrs.2020.104999
Keywords:       Duchenne Muscular Dystrophy; NHE-1; Rimeporide; Safety; Pharmacokinetic; Cardiomyopathy; 
Author:         Stefano C. Previtali
Creator:        Elsevier
CreationDate:   Fri Aug 21 16:37:12 2020 CEST
ModDate:        Fri Aug 21 16:37:12 2020 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           AcroForm
JavaScript:     no
Pages:          10
Encrypted:      no
Page size:      595.276 x 793.701 pts
Page rot:       0
File size:      833101 bytes
Optimized:      yes
PDF version:    1.7


name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
WCOROL+CharisSIL                     CID Type 0C       Identity-H       yes yes yes    541  0
CBMPFO+AdvOT596495f2                 Type 1C           WinAnsi          yes yes no     510  0
CBMPGP+AdvOT0de51fd2                 Type 1C           WinAnsi          yes yes no     511  0
CBMPIA+AdvOT596495f2+fb              Type 1C           Custom           yes yes yes    512  0
CBMPIB+AdvOT7fb33346.I               Type 1C           WinAnsi          yes yes no     522  0
CBMPIC+AdvOT7fb33346.I+fb            Type 1C           Custom           yes yes yes    523  0
CBMPJC+AdvOT596495f2+20              Type 1C           Custom           yes yes yes    531  0
CBMPJD+AdvOT8608a8d1+20              Type 1C           Custom           yes yes yes    539  0
GZMUYR+CharisSIL-Italic              CID Type 0C       Identity-H       yes yes yes    165  0
CBMPJE+AdvOT1efcda3b.B               Type 1C           WinAnsi          yes yes no     162  0
CBMPKF+AdvOT7fb33346.I+20            Type 1C           WinAnsi          yes yes no     161  0
CBNAHB+AdvOT596495f2+03              Type 1C           Custom           yes yes yes    174  0
CBNAJB+AdvOT596495f2+22              Type 1C           Custom           yes yes yes    179  0


Jhove (Rel. 1.22.1, 2019-04-17)
 Date: 2023-11-07 02:42:26 CET
 RepresentationInformation: 284154.pdf
  ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17)
  LastModified: 2023-11-06 09:56:54 CET
  Size: 833101
  Format: PDF
  Version: 1.7
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 598
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseOutlines
    Outlines: 
     Item: 
      Title: Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
      Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@66d1af89
      Children: 
       Item: 
        Title: Introduction
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@8646db9
        Children: 
         Item: 
          Title: Disease’s overview
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@37374a5e
         Item: 
          Title: Scientific rationale of Rimeporide repositioning in DMD
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4671e53b
         Item: 
          Title: Summary of clinical data with Rimeporide in adults
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@2db7a79b
       Item: 
        Title: Materials and methods
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6950e31
        Children: 
         Item: 
          Title: Investigational medicinal product
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@b7dd107
         Item: 
          Title: Study design and conduct
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@42eca56e
         Item: 
          Title: Selection of doses in the study
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@52f759d7
         Item: 
          Title: Study assessments
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7cbd213e
         Item: 
          Title: Sample management and analysis
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@192d3247
         Item: 
          Title: Quality assurance
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@3ecd23d9
         Item: 
          Title: Statistical methods and analysis
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@569cfc36
          Children: 
           Item: 
            Title: Population PK analysis
            Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@43bd930a
           Item: 
            Title: PD exploratory analysis
            Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@33723e30
       Item: 
        Title: Results
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@64f6106c
        Children: 
         Item: 
          Title: Disposition of subjects and demographics
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@553a3d88
         Item: 
          Title: Primary objective: safety of Rimeporide after repeated dosing in young DMD boys
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7a30d1e6
         Item: 
          Title: Secondary objective: pharmacokinetic profile of Rimeporide in young DMD boys
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@5891e32e
         Item: 
          Title: Exploratory pharmacodynamic biomarkers
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@cb0ed20
          Children: 
           Item: 
            Title: Imaging biomarkers
            Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@8e24743
           Item: 
            Title: Serum biomarkers
            Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@74a10858
       Item: 
        Title: Discussion
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@23fe1d71
       Item: 
        Title: Conclusions
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@28ac3dc3
       Item: 
        Title: Funding
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@32eebfca
       Item: 
        Title: Declaration of Competing Interest
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4e718207
       Item: 
        Title: Acknowledgements
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1d371b2d
       Item: 
        Title: References
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@543c6f6d
   Info: 
    Title: Rimeporide as a first- in-class NHE-1 inhibitor_ Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy
    Author: Stefano C. Previtali
    Subject: Pharmacological Research, 159 (2020) 104999. doi:10.1016/j.phrs.2020.104999
    Keywords: Duchenne Muscular Dystrophy; NHE-1; Rimeporide; Safety; Pharmacokinetic; Cardiomyopathy; 
    Creator: Elsevier
    CreationDate: Fri Aug 21 16:37:12 CEST 2020
    ModDate: Fri Aug 21 16:37:12 CEST 2020
   ID: 0x54abbb9d7556a5f99845777d26ec7b42, 0x225f1526ba66ce4d9ffcd56386d0d91f
   Filters: 
    FilterPipeline: FlateDecode
    FilterPipeline: DCTDecode
   Images: 
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 236
      ImageHeight: 298
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 248
      ImageHeight: 272
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/png
      ImageWidth: 1500
      ImageHeight: 715
      BitsPerSample: 8
      BitsPerSampleUnit: integer
     Filter: FlateDecode
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1500
      ImageHeight: 930
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
    Image: 
     NisoImageMetadata: 
      FormatName: image/jpg
      CompressionScheme: JPEG
      ImageWidth: 1058
      ImageHeight: 2596
      ColorSpace: RGB
      BitsPerSample: 8
      BitsPerSampleUnit: integer
   Fonts: 
    Type0: 
     Font: 
      BaseFont: GZMUYR+CharisSIL-Italic
      Encoding: Identity-H
      ToUnicode: true
     Font: 
      BaseFont: WCOROL+CharisSIL
      Encoding: Identity-H
      ToUnicode: true
    Type1: 
     Font: 
      BaseFont: CBMPIA+AdvOT596495f2+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 5
      FontDescriptor: 
       FontName: CBMPIA+AdvOT596495f2+fb
       Flags: Symbolic
       FontBBox: 27, 0, 921, 878
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CBMPKF+AdvOT7fb33346.I+20
      FontSubset: true
      FirstChar: 146
      LastChar: 146
      FontDescriptor: 
       FontName: CBMPKF+AdvOT7fb33346.I+20
       Flags: Nonsymbolic
       FontBBox: -503, -355, 1096, 878
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CBMPJE+AdvOT1efcda3b.B
      FontSubset: true
      FirstChar: 40
      LastChar: 121
      FontDescriptor: 
       FontName: CBMPJE+AdvOT1efcda3b.B
       Flags: Nonsymbolic
       FontBBox: -89, -257, 956, 998
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CBMPJC+AdvOT596495f2+20
      FontSubset: true
      FirstChar: 2
      LastChar: 150
      FontDescriptor: 
       FontName: CBMPJC+AdvOT596495f2+20
       Flags: Symbolic
       FontBBox: -477, -355, 1103, 878
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CBNAJB+AdvOT596495f2+22
      FontSubset: true
      FirstChar: 1
      LastChar: 138
      FontDescriptor: 
       FontName: CBNAJB+AdvOT596495f2+22
       Flags: Symbolic
       FontBBox: 4, -257, 884, 878
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CBMPIB+AdvOT7fb33346.I
      FontSubset: true
      FirstChar: 38
      LastChar: 243
      FontDescriptor: 
       FontName: CBMPIB+AdvOT7fb33346.I
       Flags: Serif, Nonsymbolic
       FontBBox: -160, -257, 1000, 980
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CBMPJD+AdvOT8608a8d1+20
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: CBMPJD+AdvOT8608a8d1+20
       Flags: Symbolic
       FontBBox: -970, -341, 2000, 1023
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CBMPIC+AdvOT7fb33346.I+fb
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: CBMPIC+AdvOT7fb33346.I+fb
       Flags: Symbolic
       FontBBox: -130, -229, 907, 878
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CBMPFO+AdvOT596495f2
      FontSubset: true
      FirstChar: 37
      LastChar: 239
      FontDescriptor: 
       FontName: CBMPFO+AdvOT596495f2
       Flags: Serif, Nonsymbolic
       FontBBox: -79, -257, 920, 984
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: CBNAHB+AdvOT596495f2+03
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: CBNAHB+AdvOT596495f2+03
       Flags: Symbolic
       FontBBox: -677, -533, 832, 1008
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: CBMPGP+AdvOT0de51fd2
      FontSubset: true
      FirstChar: 46
      LastChar: 121
      FontDescriptor: 
       FontName: CBMPGP+AdvOT0de51fd2
       Flags: Nonsymbolic
       FontBBox: -13, -250, 992, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
    CIDFontType0: 
     Font: 
      BaseFont: WCOROL+CharisSIL
      CIDSystemInfo: 
       Registry: Adobe
       Registry: Identity
       Supplement: 0
      FontDescriptor: 
       FontName: WCOROL+CharisSIL
       Flags: Serif, Symbolic
       FontBBox: -692, -533, 3000, 1270
       FontFile3: true
     Font: 
      BaseFont: GZMUYR+CharisSIL-Italic
      CIDSystemInfo: 
       Registry: Adobe
       Registry: Identity
       Supplement: 0
      FontDescriptor: 
       FontName: GZMUYR+CharisSIL-Italic
       Flags: Serif, Symbolic, Italic
       FontBBox: -716, -533, 3058, 1270
       FontFile3: true
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 5.2-c001 63.139439, 2010/09/27-13:37:26        ">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:identifier>doi:10.1016/j.phrs.2020.104999</dc:identifier>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Rimeporide as a first- in-class NHE-1 inhibitor_ Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy</rdf:li>
            </rdf:Alt>
         </dc:title>
         <dc:creator>
            <rdf:Seq>
               <rdf:li>Stefano C. Previtali</rdf:li>
               <rdf:li>Teresa Gidaro</rdf:li>
               <rdf:li>Jordi Díaz-Manera</rdf:li>
               <rdf:li>Alberto Zambon</rdf:li>
               <rdf:li>Stephanie Carnesecchi</rdf:li>
               <rdf:li>Pascale Roux-Lombard</rdf:li>
               <rdf:li>Pietro Spitali</rdf:li>
               <rdf:li>Mirko Signorelli</rdf:li>
               <rdf:li>Cristina Al-Khalili Szigyarto</rdf:li>
               <rdf:li>Camilla Johansson</rdf:li>
               <rdf:li>Julian Gray</rdf:li>
               <rdf:li>Delphine Labolle</rdf:li>
               <rdf:li>Florence Porte Thomé</rdf:li>
               <rdf:li>Jacqueline Pitchforth</rdf:li>
               <rdf:li>Joana Domingos</rdf:li>
               <rdf:li>Francesco Muntoni</rdf:li>
            </rdf:Seq>
         </dc:creator>
         <dc:subject>
            <rdf:Bag>
               <rdf:li>Duchenne Muscular Dystrophy</rdf:li>
               <rdf:li>NHE-1</rdf:li>
               <rdf:li>Rimeporide</rdf:li>
               <rdf:li>Safety</rdf:li>
               <rdf:li>Pharmacokinetic</rdf:li>
               <rdf:li>Cardiomyopathy</rdf:li>
            </rdf:Bag>
         </dc:subject>
         <dc:publisher>
            <rdf:Bag>
               <rdf:li>Elsevier</rdf:li>
            </rdf:Bag>
         </dc:publisher>
         <dc:description>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">Pharmacological Research, 159 (2020) 104999. doi:10.1016/j.phrs.2020.104999</rdf:li>
            </rdf:Alt>
         </dc:description>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/">
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Pharmacological Research</prism:publicationName>
         <prism:copyright>© 2020 The Authors. Published by Elsevier Ltd.</prism:copyright>
         <prism:issn>1043-6618</prism:issn>
         <prism:volume>159</prism:volume>
         <prism:coverDisplayDate>01 September 2020</prism:coverDisplayDate>
         <prism:pageRange>104999</prism:pageRange>
         <prism:startingPage>104999</prism:startingPage>
         <prism:doi>10.1016/j.phrs.2020.104999</prism:doi>
         <prism:url>https://doi.org/10.1016/j.phrs.2020.104999</prism:url>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:crossmark="http://crossref.org/crossmark/1.0/">
         <crossmark:MajorVersionDate>2010-04-23</crossmark:MajorVersionDate>
         <crossmark:CrossmarkDomainExclusive>true</crossmark:CrossmarkDomainExclusive>
         <crossmark:DOI>10.1016/j.phrs.2020.104999</crossmark:DOI>
         <crossmark:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>elsevier.com</rdf:li>
               <rdf:li>sciencedirect.com</rdf:li>
            </rdf:Seq>
         </crossmark:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/">
         <eMmMVnwyQoteKntaGmwr.msNNmwyOlt-RmM6GmdySngf7zgqKowuNo9ePot-Lnt-Pmt-Tma/>
         <pdfx:doi>10.1016/j.phrs.2020.104999</pdfx:doi>
         <pdfx:CrossmarkMajorVersionDate>2010-04-23</pdfx:CrossmarkMajorVersionDate>
         <pdfx:CrossmarkDomainExclusive>true</pdfx:CrossmarkDomainExclusive>
         <pdfx:robots>noindex</pdfx:robots>
         <pdfx:CrossMarkDomains>
            <rdf:Seq>
               <rdf:li>elsevier.com</rdf:li>
               <rdf:li>sciencedirect.com</rdf:li>
            </rdf:Seq>
         </pdfx:CrossMarkDomains>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:jav="http://www.niso.org/schemas/jav/1.0/">
         <jav:journal_article_version>VoR</jav:journal_article_version>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmp="http://ns.adobe.com/xap/1.0/">
         <xmp:CreatorTool>Elsevier</xmp:CreatorTool>
         <xmp:ModifyDate>2020-08-21T14:37:12Z</xmp:ModifyDate>
         <xmp:CreateDate>2020-08-21T14:37:12Z</xmp:CreateDate>
         <xmp:MetadataDate>2020-08-21T14:37:12Z</xmp:MetadataDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmpRights="http://ns.adobe.com/xap/1.0/rights/">
         <xmpRights:Marked>True</xmpRights:Marked>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Keywords>Duchenne Muscular Dystrophy; NHE-1; Rimeporide; Safety; Pharmacokinetic; Cardiomyopathy; </pdf:Keywords>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
         <xmpMM:DocumentID>uuid:ca214140-72cc-49b8-8106-870fbafee142</xmpMM:DocumentID>
         <xmpMM:InstanceID>uuid:44f0502e-6633-4b4c-8e93-56aee562f325</xmpMM:InstanceID>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:ali="http://www.niso.org/schemas/ali/1.0/">
         <ali:license_ref>
            <rdf:Bag>
               <rdf:li rdf:parseType="Resource">
                  <ali:uri>http://creativecommons.org/licenses/http://creativecommons.org/licenses/by-nc-nd/4.0//.4.0/</ali:uri>
               </rdf:li>
            </rdf:Bag>
         </ali:license_ref>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 322, 723, 369, 731
      Annotation: 
       Subtype: Link
       Rect: 274, 668, 404, 676
      Annotation: 
       Subtype: Link
       Rect: 37, 730, 37, 742
      Annotation: 
       Subtype: Link
       Rect: 128, 580, 132, 591
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 204, 580, 209, 591
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 302, 580, 306, 591
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 308, 580, 313, 591
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 395, 580, 399, 591
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 142, 567, 146, 578
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 260, 567, 262, 578
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 330, 567, 334, 578
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 417, 567, 421, 578
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 169, 554, 173, 565
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 267, 554, 270, 565
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 331, 554, 333, 565
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 419, 554, 422, 565
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 141, 541, 144, 552
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 146, 537, 151, 547
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 258, 541, 262, 552
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 346, 541, 351, 552
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 353, 541, 357, 552
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 453, 541, 457, 552
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 460, 541, 462, 552
       Destination: 482
      Annotation: 
       Subtype: Link
       Rect: 37, 75, 180, 82
      Annotation: 
       Subtype: Link
       Rect: 97, 101, 187, 108
      Annotation: 
       Subtype: Link
       Rect: 218, 747, 389, 760
      Annotation: 
       Subtype: Link
       Rect: 499, 605, 536, 623
    Page: 
     Label: 2
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 40, 663, 45, 671
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 47, 663, 52, 671
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 158, 538, 162, 546
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 160, 506, 165, 514
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 40, 496, 45, 504
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 61, 465, 66, 473
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 176, 391, 180, 399
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 70, 370, 75, 378
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 103, 318, 108, 326
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 253, 308, 258, 316
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 258, 255, 267, 263
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 172, 203, 181, 211
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 194, 140, 203, 148
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 78, 130, 87, 138
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 90, 130, 99, 138
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 254, 88, 263, 96
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 426, 716, 435, 724
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 364, 705, 373, 713
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 445, 705, 454, 713
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 520, 663, 529, 671
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 430, 653, 435, 661
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 437, 653, 446, 661
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 309, 632, 318, 640
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 369, 611, 378, 619
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 346, 590, 355, 598
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 481, 580, 490, 588
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 370, 527, 379, 535
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 514, 454, 523, 462
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 399, 402, 408, 410
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 494, 381, 503, 389
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 398, 350, 407, 357
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 409, 350, 418, 357
       Destination: 93
    Page: 
     Label: 3
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 341, 716, 361, 724
       Destination: 37
      Annotation: 
       Subtype: Link
       Rect: 324, 554, 333, 562
       Destination: 93
    Page: 
     Label: 4
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 195, 716, 204, 724
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 274, 172, 283, 180
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 266, 161, 275, 169
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 543, 297, 552, 305
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 543, 140, 552, 148
       Destination: 93
    Page: 
     Label: 5
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 68, 663, 77, 671
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 111, 568, 120, 576
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 67, 476, 87, 484
       Destination: 52
      Annotation: 
       Subtype: Link
       Rect: 125, 402, 151, 410
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 215, 381, 242, 389
       Destination: 64
      Annotation: 
       Subtype: Link
       Rect: 469, 549, 496, 557
       Destination: 67
      Annotation: 
       Subtype: Link
       Rect: 460, 329, 469, 337
       Destination: 93
    Page: 
     Label: 6
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 400, 278, 426, 286
       Destination: 67
    Page: 
     Label: 7
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 560, 313, 560, 321
       Destination: 75
      Annotation: 
       Subtype: Link
       Rect: 306, 302, 333, 310
       Destination: 75
      Annotation: 
       Subtype: Link
       Rect: 405, 250, 426, 258
       Destination: 88
      Annotation: 
       Subtype: Link
       Rect: 343, 177, 352, 185
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 355, 177, 363, 185
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 525, 156, 534, 164
       Destination: 93
    Page: 
     Label: 8
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 158, 333, 167, 341
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 71, 103, 80, 111
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 82, 103, 91, 111
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 274, 61, 283, 69
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 274, 51, 283, 59
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 309, 521, 318, 529
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 321, 521, 330, 529
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 332, 521, 341, 529
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 521, 511, 530, 519
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 510, 490, 519, 498
       Destination: 93
      Annotation: 
       Subtype: Link
       Rect: 398, 448, 407, 456
       Destination: 93
    Page: 
     Label: 9
    Page: 
     Label: 10
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 185, 288, 282, 294
      Annotation: 
       Subtype: Link
       Rect: 148, 265, 255, 271
      Annotation: 
       Subtype: Link
       Rect: 163, 250, 284, 256
      Annotation: 
       Subtype: Link
       Rect: 53, 243, 87, 249
      Annotation: 
       Subtype: Link
       Rect: 174, 220, 275, 226
      Annotation: 
       Subtype: Link
       Rect: 53, 212, 73, 218
      Annotation: 
       Subtype: Link
       Rect: 118, 190, 238, 196
      Annotation: 
       Subtype: Link
       Rect: 256, 174, 287, 180
      Annotation: 
       Subtype: Link
       Rect: 53, 167, 114, 173
      Annotation: 
       Subtype: Link
       Rect: 53, 159, 288, 165
      Annotation: 
       Subtype: Link
       Rect: 53, 152, 222, 158
      Annotation: 
       Subtype: Link
       Rect: 246, 137, 288, 143
      Annotation: 
       Subtype: Link
       Rect: 53, 129, 118, 135
      Annotation: 
       Subtype: Link
       Rect: 93, 114, 217, 120
      Annotation: 
       Subtype: Link
       Rect: 182, 99, 275, 105
      Annotation: 
       Subtype: Link
       Rect: 53, 68, 173, 74
      Annotation: 
       Subtype: Link
       Rect: 526, 719, 557, 725
      Annotation: 
       Subtype: Link
       Rect: 322, 711, 438, 717
      Annotation: 
       Subtype: Link
       Rect: 369, 689, 492, 695
      Annotation: 
       Subtype: Link
       Rect: 355, 666, 466, 672
      Annotation: 
       Subtype: Link
       Rect: 444, 651, 553, 657
      Annotation: 
       Subtype: Link
       Rect: 322, 643, 357, 649
      Annotation: 
       Subtype: Link
       Rect: 322, 636, 550, 642
      Annotation: 
       Subtype: Link
       Rect: 322, 628, 545, 634
      Annotation: 
       Subtype: Link
       Rect: 322, 621, 412, 627
      Annotation: 
       Subtype: Link
       Rect: 523, 605, 554, 611
      Annotation: 
       Subtype: Link
       Rect: 322, 598, 408, 604
      Annotation: 
       Subtype: Link
       Rect: 322, 590, 557, 596
      Annotation: 
       Subtype: Link
       Rect: 322, 583, 553, 589
      Annotation: 
       Subtype: Link
       Rect: 322, 575, 399, 581
      Annotation: 
       Subtype: Link
       Rect: 355, 552, 492, 558
      Annotation: 
       Subtype: Link
       Rect: 375, 530, 497, 536
      Annotation: 
       Subtype: Link
       Rect: 461, 515, 557, 521
      Annotation: 
       Subtype: Link
       Rect: 322, 507, 356, 513
      Annotation: 
       Subtype: Link
       Rect: 434, 484, 557, 490
      Annotation: 
       Subtype: Link
       Rect: 385, 462, 504, 468
      Annotation: 
       Subtype: Link
       Rect: 504, 446, 555, 452
      Annotation: 
       Subtype: Link
       Rect: 322, 439, 382, 445
      Annotation: 
       Subtype: Link
       Rect: 506, 401, 557, 407
      Annotation: 
       Subtype: Link
       Rect: 322, 393, 395, 399
      Annotation: 
       Subtype: Link
       Rect: 526, 378, 557, 384
      Annotation: 
       Subtype: Link
       Rect: 322, 371, 413, 377
      Annotation: 
       Subtype: Link
       Rect: 322, 363, 540, 369
      Annotation: 
       Subtype: Link
       Rect: 322, 356, 528, 362
      Annotation: 
       Subtype: Link
       Rect: 322, 348, 550, 354
      Annotation: 
       Subtype: Link
       Rect: 322, 340, 548, 346
      Annotation: 
       Subtype: Link
       Rect: 322, 333, 347, 339
      Annotation: 
       Subtype: Link
       Rect: 378, 318, 509, 324
      Annotation: 
       Subtype: Link
       Rect: 322, 310, 557, 316
      Annotation: 
       Subtype: Link
       Rect: 322, 303, 557, 309
      Annotation: 
       Subtype: Link
       Rect: 322, 295, 534, 301
      Annotation: 
       Subtype: Link
       Rect: 322, 287, 449, 293
      Annotation: 
       Subtype: Link
       Rect: 448, 272, 529, 278
      Annotation: 
       Subtype: Link
       Rect: 322, 265, 357, 271
      Annotation: 
       Subtype: Link
       Rect: 526, 250, 557, 256
      Annotation: 
       Subtype: Link
       Rect: 322, 242, 391, 248
      Annotation: 
       Subtype: Link
       Rect: 467, 227, 549, 233
      Annotation: 
       Subtype: Link
       Rect: 322, 219, 377, 225
      Annotation: 
       Subtype: Link
       Rect: 369, 197, 477, 203
      Annotation: 
       Subtype: Link
       Rect: 453, 174, 553, 180
      Annotation: 
       Subtype: Link
       Rect: 322, 166, 342, 172
      Annotation: 
       Subtype: Link
       Rect: 420, 144, 555, 150
      Annotation: 
       Subtype: Link
       Rect: 486, 121, 553, 127
      Annotation: 
       Subtype: Link
       Rect: 322, 113, 378, 119
      Annotation: 
       Subtype: Link
       Rect: 470, 91, 552, 97
      Annotation: 
       Subtype: Link
       Rect: 322, 83, 340, 89
  Checksum: 8f9e93ea
   Type: CRC32
  Checksum: 34c39814f65275e66202c64aeb4daa64
   Type: MD5
  Checksum: 0da9f89c63bba5ff3a08440588b0efde8923e698
   Type: SHA-1